CXCL12 and cancer: We compared the single-cell data of MDA-MB-231 cancer cells preconditioned with either 100 nM alpelisib, 10 nM trametinib, and 10 μM SB203580 two hours prior to the addition of a CXCL12 gradient (Figure 5A).